Given the important role of TIGIT expression on B cells in maintaining CNS tolerance in murine models (31), we focused on the significant downregulation of TIGIT on MS patient–derived memory B cells (log2 FC = –0.54, FDR = 0.01). This evidence concerns the gene TIGIT and myeloid sarcoma.